Elena Giammartini

Phenotypic and functional characterization of monocyte‐derived dendritic cells in chronic lymphocytic leukaemia patients: influence of neoplastic CD19+ cells in vivo and in vitro

R. Foà, A. Guarini, R. Maggio, 2004, British journal of haematology.

Fludarabine , araC , novantrone and dexamethasone ( FAND ) in previously treated chronic lymphocytic leukemia patients

Mauro, R. Foà, F. Mandelli, 2002 .

Clinical features and outcome of familial chronic lymphocytic leukemia.

R. Foà, A. Pizzuti, A. Guarini, 2006, Haematologica.

The prognostic value of CD38 expression in chronic lymphocytic leukaemia patients studied prospectively at diagnosis: a single institute experience

F. Mancini, R. Foà, A. Guarini, 2005, British journal of haematology.

Fludarabine, ara-C, novantrone and dexamethasone (FAND) in previously treated chronic lymphocytic leukemia patients.

R. Foà, F. Mandelli, G. Meloni, 2002, Haematologica.

Fludarabine, Ara-c, novantrone and dexamethasone plus Campath-1H for the treatment of patients with chronic lymphocytic leukemia (CLL) and adverse clinical and biologic prognostic features.

Emanuela M. Ghia, R. Foà, A. Guarini, 2006 .